FDMT4D Molecular Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 15225
Ticker: FDMT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-12-11
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: FDMT

Detail

Enriched 2026-08-14 20:47

Market cap: $620,519,134.98
Shares outstanding (class): 52,276,254
Shares outstanding (weighted): 52,276,254
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 196
Location: EMERYVILLE, CA
Homepage: https://www.4dmoleculartherapeutics.com
Description: 4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Market cap and share counts drift.

Funds holding this security

87 funds · 89 positions · $73.75M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$15.88M	0.00%	1,706,213 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$12.27M	0.17%	1,318,068 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$9.96M	0.01%	1,070,300 NS	FIGI
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$7.86M	0.15%	843,751 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$4.11M	0.01%	441,655 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$3.52M	0.03%	378,230 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$3.15M	0.04%	338,744 NS	FIGI
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$2.89M	0.12%	310,950 NS	FIGI
Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust	—	$2.66M	0.03%	286,101 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$1.04M	0.09%	111,291 NS	FIGI
Federated Hermes MDT Small Cap Value Fund f/k/a… Federated Hermes Equity Funds	—	$984.7K	0.66%	105,765 NS	FIGI
Simplify Propel Opportunities ETF Simplify Exchange Traded Funds	SURI	$655.7K	0.95%	70,430 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$630.3K	0.01%	67,699 NS	FIGI
College Retirement Equities Fund - Total Global… College Retirement Equities Fund	—	$569.4K	0.00%	61,165 NS	FIGI
JPMorgan U.S. Small Company Fund JPMorgan Trust I	—	$530.9K	0.06%	57,027 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERFDMT
FIGI_COMPOSITEBBG00QG40R88
FIGI_SHARE_CLASSBBG00QG40S04
CIK0001650648
ISINUS35104E1001
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: 4D Molecular Therapeutics is a biotech company developing gene therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.